Published in J Clin Pathol on April 01, 2009
Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease. Hum Genet (2013) 2.44
Germline BRCA1 mutations increase prostate cancer risk. Br J Cancer (2012) 1.45
Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain). BMC Cancer (2013) 0.88
The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers. Front Biosci (Landmark Ed) (2014) 0.88
Genotype-phenotype correlations among BRCA1 4153delA and 5382insC mutation carriers from Latvia. BMC Med Genet (2011) 0.82
Prevalence of the BRCA1 c.68_69delAG (BIC: 185delAG) mutation in women with breast cancer from north-central Poland and a review of the literature on other regions of the country. Contemp Oncol (Pozn) (2013) 0.78
Breast and ovarian cancer risk evaluation in families with a disease-causing mutation in BRCA1/2. J Community Genet (2010) 0.77
Genotype-Phenotype Correlations by Ethnicity and Mutation Location in BRCA Mutation Carriers. Breast J (2015) 0.75
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science (1994) 36.53
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet (2003) 18.67
Linkage of early-onset familial breast cancer to chromosome 17q21. Science (1990) 16.21
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet (1998) 15.09
Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet (1994) 9.60
Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science (1994) 8.73
On the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst (2002) 7.64
Cancer Incidence in BRCA1 mutation carriers. J Natl Cancer Inst (2002) 6.58
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet (1996) 6.43
Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat Genet (1995) 4.86
A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet (1996) 4.38
BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med (1997) 4.33
Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet (1997) 4.16
Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet (2001) 3.75
Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nat Genet (1996) 3.56
Population genetics of BRCA1 and BRCA2. Am J Hum Genet (1997) 3.28
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol (1998) 2.55
The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons. Hum Mol Genet (2002) 2.38
The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. The BRCA1 Exon 13 Duplication Screening Group. Am J Hum Genet (2000) 1.95
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet (2005) 1.91
Modifiers of risk of hereditary breast and ovarian cancer. Nat Rev Cancer (2002) 1.63
Bias and efficiency in family-based gene-characterization studies: conditional, prospective, retrospective, and joint likelihoods. Am J Hum Genet (2000) 1.62
Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia. Am J Hum Genet (1997) 1.62
Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. Am J Hum Genet (1998) 1.61
The 185delAG mutation (c.68_69delAG) in the BRCA1 gene triggers translation reinitiation at a downstream AUG codon. Hum Mutat (2006) 1.58
A marginal likelihood approach for estimating penetrance from kin-cohort designs. Biometrics (2001) 1.49
A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. Am J Hum Genet (1996) 1.45
Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing. Am J Hum Genet (2000) 1.34
Mutations and alternative splicing of the BRCA1 gene in UK breast/ovarian cancer families. Genes Chromosomes Cancer (1997) 1.03
Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients. Int J Cancer (2006) 1.01
Cancer incidence in Jewish migrants to Israel, 1961-1981. IARC Sci Publ (1989) 0.95
Detection of a novel Alu-mediated BRCA1 exon 13 duplication in Chinese breast cancer patients and implications for genetic testing. Clin Genet (2006) 0.82
Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (1986) 211.50
Repetitive zinc-binding domains in the protein transcription factor IIIA from Xenopus oocytes. EMBO J (1985) 20.39
Diagnostic tests 2: Predictive values. BMJ (1994) 12.97
A physical map of 30,000 human genes. Science (1998) 12.43
The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med (2001) 11.48
Diagnostic tests. 1: Sensitivity and specificity. BMJ (1994) 11.35
A new system for grading recommendations in evidence based guidelines. BMJ (2001) 11.13
Absence of evidence is not evidence of absence. BMJ (1995) 10.36
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science (2001) 9.09
A comprehensive genetic map of the mouse genome. Nature (1996) 6.94
Statistics notes: the normal distribution. BMJ (1995) 6.82
Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase. Science (2001) 6.29
Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature (1996) 6.17
Comparison of clinical information gained from routine blood-gas analysis and from gastric tonometry for intramural pH. Lancet (1993) 5.90
Statistics notes. Treatment allocation in controlled trials: why randomise? BMJ (1999) 5.86
Multi-system neurological disease is common in patients with OPA1 mutations. Brain (2010) 5.37
How to randomise. BMJ (1999) 5.24
A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science (1991) 5.14
A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature (1988) 5.11
Air pollution and daily mortality in London: 1987-92. BMJ (1996) 4.97
Comparing several groups using analysis of variance. BMJ (1996) 4.89
Effects of a decision support system on the diagnostic accuracy of users: a preliminary report. J Am Med Inform Assoc (1997) 4.61
Time to event (survival) data. BMJ (1998) 4.29
The natural history of asthma in childhood. J Epidemiol Community Health (1986) 4.09
The intracluster correlation coefficient in cluster randomisation. BMJ (1998) 4.07
Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis. Lancet (1972) 3.90
Effects on birth weight of smoking, alcohol, caffeine, socioeconomic factors, and psychosocial stress. BMJ (1989) 3.83
The development of respiratory symptoms in a cohort of Kent schoolchildren. Bull Physiopathol Respir (Nancy) (1975) 3.78
Diagnostic tests 3: receiver operating characteristic plots. BMJ (1994) 3.73
Health literacy and health-related knowledge among persons living with HIV/AIDS. Am J Prev Med (2000) 3.70
Effectiveness of acute postoperative pain management: I. Evidence from published data. Br J Anaesth (2002) 3.60
Surgery on the rheumatoid cervical spine for the non-ambulant myelopathic patient-too much, too late? Lancet (1996) 3.52
Divided attention: evidence for coactivation with redundant signals. Cogn Psychol (1982) 3.28
Incidence of pregnancy after laparoscopy and hydrotubation. Br Med J (Clin Res Ed) (1982) 3.11
Analysis of a trial randomised in clusters. BMJ (1998) 3.10
Phylogenetic diversity of bacterial and archaeal communities in the anoxic zone of the Cariaco Basin. Appl Environ Microbiol (2001) 3.06
Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem (1996) 3.05
Genetic studies of the Lac repressor. XV: 4000 single amino acid substitutions and analysis of the resulting phenotypes on the basis of the protein structure. J Mol Biol (1996) 2.98
Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem (1996) 2.95
Detecting skewness from summary information. BMJ (1996) 2.88
Sample size in cluster randomisation. BMJ (1998) 2.82
Nutrition and factors limiting the growth of a methanogenic bacterium (Methanobacterium thermoautotrophicum). Arch Microbiol (1977) 2.71
Quartiles, quintiles, centiles, and other quantiles. BMJ (1994) 2.68
Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study. Ann Oncol (2010) 2.64
Factors associated with the starting of cigarette smoking by primary school children. Br J Prev Soc Med (1974) 2.61
Evidence for high-energy extraterrestrial neutrinos at the IceCube detector. Science (2013) 2.56
Efficient cell surface expression of class II MHC molecules in the absence of associated invariant chain. J Exp Med (1986) 2.55
Preterm delivery: effects of socioeconomic factors, psychological stress, smoking, alcohol, and caffeine. BMJ (1995) 2.54
Long-term study of smoking by secondary schoolchildren. Arch Dis Child (1978) 2.54
A radiation hybrid map of the rat genome containing 5,255 markers. Nat Genet (1999) 2.54
Widespread West Nile virus activity, eastern United States, 2000. Emerg Infect Dis (2001) 2.52
A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation (1997) 2.46
Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett (1998) 2.40
Prolonged expiratory apnoea: a disorder resulting in episodes of severe arterial hypoxaemia in infants and young children. Lancet (1985) 2.36
Diffusion tensor imaging of normal and injured developing human brain - a technical review. NMR Biomed (2002) 2.36
Strength of the cement-bone interface. Clin Orthop Relat Res (1982) 2.31
Isolation and characterization of the human pulmonary surfactant apoprotein gene. Nature (1985) 2.27
Randomised controlled trial of effects of coordinating care for terminally ill cancer patients. BMJ (1992) 2.26
Comparison of laparoscopic and open ventral herniorrhaphy. Am Surg (1999) 2.23
Prognostic importance of emotional support for elderly patients hospitalized with heart failure. Circulation (1998) 2.21
Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy. AIDS (2001) 2.17
Puerperal thromboembolism in relation to the inhibition of lactation by oestrogen therapy. Br Med J (1968) 2.17
Dead crow densities and human cases of West Nile virus, New York State, 2000. Emerg Infect Dis (2001) 2.17
Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis. Lancet (1994) 2.15
Academic performance and social factors related to cigarette smoking by schoolchildren. Br J Prev Soc Med (1977) 2.15
Intraosseous infusion: an alternative route of pediatric intravascular access. Ann Emerg Med (1985) 2.14
Emergency caesarean section in a patient with myotonic dystrophy: a case of failed postoperative extubation in a patient with mild disease. Anaesth Intensive Care (2011) 2.14
Serum insulin-like growth factor-1 is not a useful marker of prostate cancer. BJU Int (1999) 2.14
Morphometric analysis of recombinant soluble CD4-mediated release of the envelope glycoprotein gp120 from HIV-1. AIDS Res Hum Retroviruses (1990) 2.13
Specific antigen-Ia activation of transfected human T cells expressing murine Ti alpha beta-human T3 receptor complexes. Nature (1987) 2.11
Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates. Infect Immun (1983) 2.10
Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center. Clin Infect Dis (2001) 2.09
Prenatal diagnosis of genetic disease in Canada: report of a collaborative study. Can Med Assoc J (1976) 2.07
Seasonality of births in schizophrenia and bipolar disorder: a review of the literature. Schizophr Res (1997) 2.06
Rearrangement of immunoglobulin genes. Biochemistry (1979) 2.04
A new, minimally invasive technique for measuring cardiac index: clinical comparison of continuous cardiac dynamic monitoring and pulmonary artery catheter methods. Anaesthesia (2009) 2.04
Isolation and sequence analysis of the human apolipoprotein CIII gene and the intergenic region between the apo AI and apo CIII genes. DNA (1984) 2.04
Expression and functional significance of an additional ligand for CTLA-4. Proc Natl Acad Sci U S A (1993) 2.03
Substrate specificity of Fpg protein. Recognition and cleavage of oxidatively damaged DNA. J Biol Chem (1994) 2.03
Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta (1983) 2.03
The 58,000-dalton cellular inhibitor of the interferon-induced double-stranded RNA-activated protein kinase (PKR) is a member of the tetratricopeptide repeat family of proteins. Mol Cell Biol (1994) 2.03
Negotiating risks in context: a perspective on unprotected anal intercourse and barebacking among men who have sex with men--where do we go from here? Arch Sex Behav (2001) 2.02
Effects of air pollution on daily hospital admissions for respiratory disease in London between 1987-88 and 1991-92. J Epidemiol Community Health (1996) 2.02
Is the clinical trial evidence about new drugs statistically adequate? Br J Clin Pharmacol (1985) 2.01
Smoking and respiratory symptoms in two groups of schoolchildren. Prev Med (1976) 2.01
First observation of PeV-energy neutrinos with IceCube. Phys Rev Lett (2013) 2.00
Nucleotide sequence and expression of a mouse interleukin 2 receptor cDNA. J Immunol (1985) 2.00
Purification of Torpedo californica post-synaptic membranes and fractionation of their constituent proteins. Biochem J (1980) 1.99
Health effects of an air pollution episode in London, December 1991. Thorax (1995) 1.98
Ethnic variation in respiratory morbidity and lung function in childhood. Thorax (1987) 1.94
Unequal cluster sizes for trials in English and Welsh general practice: implications for sample size calculations. Stat Med (2001) 1.93
B vitamins, homocysteine, and neurocognitive function in the elderly. Am J Clin Nutr (2000) 1.92
Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest (1989) 1.91
Selective peptide antagonist of the class E calcium channel from the venom of the tarantula Hysterocrates gigas. Biochemistry (1998) 1.89
Sex-specific antenatal reference growth charts for uncomplicated singleton pregnancies at 15-40 weeks of gestation. Ultrasound Obstet Gynecol (2004) 1.89
Atrial natriuretic peptide clearance receptor. Complete sequence and functional expression of cDNA clones. J Biol Chem (1988) 1.88
Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol Cell Biol (1994) 1.88
Plasma proinflammatory cytokine concentrations, Acute Physiology and Chronic Health Evaluation (APACHE) III scores and survival in patients in an intensive care unit. Crit Care Med (1996) 1.86
Isolation of a cDNA clone encoding the amino-terminal region of human apolipoprotein B. Proc Natl Acad Sci U S A (1986) 1.86